Bookmark this page
Share this page
DONATE NOW
JOIN THE MMRF TODAY!
SEARCH
BLOG
|
MEDIA ROOM
|
CONTACT US
Powerful Mission
Powerful Model
Leadership
Results
Financial Reports
Powerful News
Employment Opportunities
Newly Diagnosed Patients
Patients Starting Treatment
Relapsed/Refractory Patients
Educational Programs
Additional Resources
Results
Scientific Agenda
For Academic Researchers
For Industry
Ways to Donate
Join an Event
Shop MMRF
Powerful Mission
Powerful Model
Leadership
Results
Financial Reports
Powerful News
MMRF Press Releases
MMRF In the News
MMRF Blog
MMRF Media Room
MMRF Newsletters
MMRF Social Networking
Employment Opportunities
POWERFUL NEWS
2009
10/27/09
—
Multiple Myeloma Research Foundation's (MMRF) Fall Gala Raises More Than $1.8 Million to Advance Cancer Research
...
10/19/09
—
Harvard Business School Awards MMRF Founder, CEO with Alumni Achievement Award
...
09/14/09
—
Sports Legends and Broadcast Personalities Headline Multiple Myeloma Research Foundation's 13TH Annual Fall Gala
...
08/03/09
—
Hoda Kotb and Boomer Esiason to join Multiple Myeloma Research Foundation (MMRF) at 13th Annual Fall Gala
...
07/27/09
—
MMRC Multiple Myeloma Genomics Initiative First to Sequence Complete Myeloma Genomes
...
06/18/09
—
Multiple Myeloma Research Consortium (MMRC) Activates Clinical Trials 30-40 Percent Faster Than Industry Standard
...
05/18/09
—
MMRF and the Broad Institute of MIT and Harvard Announce Collaboration to Perform Whole Genome Sequencing of Multiple Myeloma Samples
...
05/18/09
—
Cancer Research Partnership Between UCSF, MMRF to Drive Drug Development
...
04/14/09
—
AACR Awards Centennial Medals for Distinguished Public Service
...
03/02/09
—
Multiple Myeloma Research Foundation (MMRF) Grants $1.0 Million to Aileron Therapeutics and Astex Therapeutics to Advance New Therapies for Multiple Myeloma
...
02/16/09
—
The Multiple Myeloma Research Foundation (MMRF) and Leukemia & Lymphoma Society (LLS) Partner to Fund $500,000 in Cancer Stem Cell Research Grants
...
01/16/09
—
Multiple Myeloma Research Consortium (MMRC) and Merck initiate Phase II Trial of Zolinza with Velcade in Relapsed and Refractory Multiple Myeloma Patients
...
View Older Press Releases
nonprofit software